Source: Genomeweb

Indivumed GmbH: Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research

Indivumed and the Oslo University Hospital's Institute for Cancer Genetics and Informatics will develop algorithms to automate colorectal cancer prognoses.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Hartmut Juhl's photo - Founder & CEO of Indivumed GmbH

Founder & CEO

Hartmut Juhl

CEO Approval Rating

82/100

Read more